RET expression is relatively low in colon adenocarcinoma and several studies have noted frequent methylation of the RET promoter, suggesting reduced RET expression may be associated with worse prognosis in some cases (Luo et al., 2013; Draht et al., 2014). This evidence concerns the gene RET and colon adenocarcinoma.